DeutschNewstral
Article
bizjournals.com on 2018-04-06 22:57
Clovis Oncology ovarian cancer drug receives fast-tracked FDA approval
Related news
- Clovis Oncology's ovarian cancer drug wins FDA approvalbizjournals.com
- MClovis Oncology stock rises 10% premarket after 'breakthrough' designation from FDAmarketwatch.com
- MClovis Oncology's ovarian cancer treatment gets FDA OKmarketwatch.com
Stamford’s Loxo Oncology receives FDA approval on cancer drugwestfaironline.com
Tesaro Receives Early FDA Approval for Ovarian Cancer Drug Zejulajdsupra.com- Clovis Oncology raising $275 million for cancer drug developmentbizjournals.com
FDA Panel Opposes Approval of Clovis Lung-Cancer Treatmentwsj.com- Clovis Oncology shares surge after FDA called its cancer drug a 'breakthrough'bizjournals.com
- Waltham's Tesaro just got one step closer to winning FDA approval for its ovarian cancer drugbizjournals.com
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress'Fox News
OU-tested ovarian cancer drug garners approval for use from FDAjournalrecord.com- FDA delays Clovis lung cancer drug; shares sink Mondaybizjournals.com
- Clovis boosted by FDA acceptance of cancer drugbizjournals.com
- Clovis Oncology commencing $250 million stock offeringbizjournals.com
US FDA clears ovarian cancer drug for hard-to-treat diseaseKRQE News 13- Loxo Oncology treatment earns FDA special designationwestfaironline.com
- Expanding Compliance Obligations of the Board – Part 2: Clovis Oncologyjdsupra.com
- MClovis shares jump as FDA grants priority review to cancer treatmentmarketwatch.com
- Clovis gets European regulatory OK for its ovarian cancer drugbizjournals.com
- Clovis gets good ovarian cancer drug news; shares soarbizjournals.com